Roche invests over 600 million euros in high-tech production centre for diagnostics

The new centre relies on state-of-the-art technologies, including automated production processes and flexible "multi-purpose systems", which enable the rapid manufacture of new generations of diagnostic products. Sustainability also plays an important role: photovoltaic systems and a biomass cogeneration plant are intended to reduce the site's CO2 footprint. By 2025, Roche aims to save around 7,800 tonnes of CO2 per year through these measures. Roche has invested more than three billion euros in its German sites over the past five years, including 1.3 billion euros in Penzberg. The site is a global centre for the production of diagnostic starting materials and part of the life science ecosystem in the Munich region. With over 7,700 employees, including 309 trainees, Roche is a major employer and driver of innovation in Bavaria. The new production centre will not only revolutionise diagnostics production, but will also improve collaboration and efficiency by consolidating all diagnostics activities under one roof. This underlines the strategic importance of the site for global healthcare.